inflammatory bowel disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: IBD patients who undergoing gastrointestinal endoscopy Other patients who undergoing gastrointestinal endoscopy
Exclusion criteria
Exclusion criteria: Patients who reject to participate in this study Patients with infectious disease that requires notification under the Infectious Diseases Control Law Patients who are considered to be unsuitable to this study for any other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The components of mucosa-associated microbiota and the impact on the pathology of IBD | — |
Secondary
| Measure | Time frame |
|---|---|
| The association of mucosa-associated microbiota and treatment history | — |
Countries
Japan
Contacts
Shiga University of Medical Science Division of Gastroenterology, Department of Medicine